GB1219219A - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB1219219A GB1219219A GB2428569A GB2428569A GB1219219A GB 1219219 A GB1219219 A GB 1219219A GB 2428569 A GB2428569 A GB 2428569A GB 2428569 A GB2428569 A GB 2428569A GB 1219219 A GB1219219 A GB 1219219A
- Authority
- GB
- United Kingdom
- Prior art keywords
- androstane
- pharmaceutical compositions
- norandrostane
- dioxolane
- dioxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Abstract
1,219,219. A-nor-steroids. MERCK & CO. Inc. 13 May, 1969, No. 24286/69. Addition to 1,169,740. Heading C2C. [Also in Division A5] 2α,16α - Diethynyl - A - nor - androstane - 2#, 16#-diol is prepared from 2-oxo-A-nor-androstane - 17# - ol via 2 - dioxolane - A - norandrostane-17#-ol; the corresponding -17-one; A-nor-androstane-16-oximino-2,17-dione 2-dioxolane; 2,16 - dioxo - A - nor - androstane - 17- ol; 2,16 - dioxo - 17 - tosyloxy - A - norandrostane; 2 - hydroxy - A - nor - androstane- 16-one and A-nor-androstane-2,16-dione.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2428569A GB1219219A (en) | 1969-05-13 | 1969-05-13 | Pharmaceutical compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2428569A GB1219219A (en) | 1969-05-13 | 1969-05-13 | Pharmaceutical compositions |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1219219A true GB1219219A (en) | 1971-01-13 |
Family
ID=10209299
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB2428569A Expired GB1219219A (en) | 1969-05-13 | 1969-05-13 | Pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB1219219A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434444A (en) * | 2014-09-29 | 2016-03-30 | 上海奥奇医药科技有限公司 | Oral preparation containing A-nor-5 alpha androstane compound |
-
1969
- 1969-05-13 GB GB2428569A patent/GB1219219A/en not_active Expired
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105434444A (en) * | 2014-09-29 | 2016-03-30 | 上海奥奇医药科技有限公司 | Oral preparation containing A-nor-5 alpha androstane compound |
WO2016050193A1 (en) * | 2014-09-29 | 2016-04-07 | 陈雅君 | Oral formulation of a-nor-5α androstane compound |
AU2015327509B2 (en) * | 2014-09-29 | 2018-04-26 | Yajun Chen | Oral formulation of A-nor-5a androstane compound |
US10537583B2 (en) | 2014-09-29 | 2020-01-21 | Yajun CHEN | Oral formulation of A-nor-5α androstane compound |
EP3202404B1 (en) * | 2014-09-29 | 2024-03-27 | Yajun Chen | Oral formulation of a-nor-5alpha androstane compound |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1333317A (en) | Substituted glutaronitriles as antijungal agents | |
GB1461062A (en) | Oxygenated tricyclic derivatives as perfuming and flavouring agents | |
GB1219219A (en) | Pharmaceutical compositions | |
GB1301555A (en) | ||
GB1270049A (en) | New pharmaceutical product | |
GB1363404A (en) | Epoxides | |
GB1457144A (en) | Cephalosporin derivatives | |
ES426711A1 (en) | 17{62 -hydroxy-16,16-dimethylester-4-en-3-one | |
GB1435685A (en) | Hydroxyl-subst | |
GB1333615A (en) | Cyclopentane derivatives | |
GB1449146A (en) | Prostaglandins and the preparation thereof | |
GB1235768A (en) | 6,7 - methylene - 20 - spiroxanes | |
GB1433845A (en) | Phar | |
GB1322766A (en) | Tricarbocyanine dyes | |
GB1252995A (en) | ||
GB1255891A (en) | Cyclopentapyrimidine derivative | |
GB1195943A (en) | Novel 17-Valerates of 6,9-Difluoro-Steroids | |
ES374657A1 (en) | Substituted derivatives of 1,1-dichloroalkene-1 and their preparation and uses | |
GB1270373A (en) | 6-chloropregnadienes | |
GB1377355A (en) | Caryophyllan derivatives | |
GB1463908A (en) | 1-dimethylamino-methyl-6-substituted-4h-s-triazolo-4,3-a- 1,4-benzodiazepine | |
GB852336A (en) | Improvements in or relating to hinges | |
GB1371693A (en) | 4,6-dihydro-1,3-dimethyl-4-ethyl-8-phenylpyrazolo-4,3-e-1,4- diazepin-5-1h-one and compositions containing the same | |
GB1184680A (en) | Preparation of (1-Alkyl-5-Nitroimidazol-2-yl) Alkyl Carbamates | |
GB1232093A (en) |